Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant ITGAL (Efalizumab Biosimilar) antibody

Reactivity: Human BR, FACS Host: Human Monoclonal hu1124 unconjugated Recombinant Antibody
Catalog No. ABIN5668044
  • Target See all ITGAL (Efalizumab Biosimilar) products
    ITGAL (Efalizumab Biosimilar)
    Antibody Type
    Recombinant Antibody
    Reactivity
    Human
    Host
    • 1
    • 1
    Human
    Clonality
    • 2
    Monoclonal
    Conjugate
    • 2
    This ITGAL (Efalizumab Biosimilar) antibody is un-conjugated
    Application
    Blocking Reagent (BR), Flow Cytometry (FACS)
    Specificity
    Binds to human LFA-1.
    Characteristics

    OriginalSpeciesName: Human

    OriginalFormat: IgG1

    Purification
    Purified antibody.
    Purity
    > 98 % as determined by SDS-PAGE
    Endotoxin Level
    Endotoxin is < 1.0 EU/mg as determined by the LAL method
    Immunogen
    Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes.
    Clone
    Hu1124
    Isotype
    IgG1 kappa
  • Application Notes
    Efalizumab binds to the LFA-1 alpha I domain blocking the ICAM-1 binding site via steric hindrance.
    Restrictions
    For Research Use only
  • Buffer
    PBS with 0.02 % Proclin 300.
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Storage Comment
    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target
    ITGAL (Efalizumab Biosimilar)
    Abstract
    ITGAL (Efalizumab Biosimilar) Products
    Synonyms
    CD11A antibody, LFA-1 antibody, LFA1A antibody, integrin subunit alpha L antibody, ITGAL antibody
    Target Type
    Biosimilar
    Background
    LFA-1, integrin alpha L
    UniProt
    P20701
You are here:
Support